Northern Trust’s TriSalus Life Sciences TLSI Stock Holding History

Northern Trust’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.73M	Buy	379,572 +158,099	+71%	+$628K	﹤0.01%	3217
2026 Q1	$886K	Sell	221,473 -761	-0.3%	-$3.73K	﹤0.01%	3392
2025 Q4	$1.55M	Buy	222,234 +45,580	+26%	+$255K	﹤0.01%	3140
2025 Q3	$821K	Buy	176,654 +50,391	+40%	+$236K	﹤0.01%	3478
2025 Q2	$688K	Buy	126,263 +86,337	+216%	+$463K	﹤0.01%	3545
2025 Q1	$220K	Buy	39,926 +7,814	+24%	+$41.6K	﹤0.01%	3912
2024 Q4	$161K	Buy	32,112 +5,936	+23%	+$25.1K	﹤0.01%	4051
2024 Q3	$121K	Hold	26,176	–	–	﹤0.01%	4008
2024 Q2	$144K	Sell	26,176 -2,247	-8%	-$19.1K	﹤0.01%	3956
2024 Q1	$277K	Buy	28,423 +10,233	+56%	+$94.5K	﹤0.01%	3774
2023 Q4	$154K	Buy	+18,190	New	+$93.6K	﹤0.01%	3992

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Northern Trust's TLSI Position: Q2 2026 in Review

Northern Trust increased its TriSalus Life Sciences (TLSI) stake by 71% in Q2 2026, buying an estimated $628K and bringing the position to 379,572 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3217.

Northern Trust first reported a position in TLSI in Q4 2023 and has held it in 11 quarters since. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Northern Trust held 379,572 shares of TriSalus Life Sciences worth $1.73M as of Q2 2026.
Northern Trust bought 158,099 TriSalus Life Sciences shares in Q2 2026, an estimated $628K.
TriSalus Life Sciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3217 holding.
Northern Trust first reported a position in TriSalus Life Sciences in Q4 2023 and has held it in 11 quarters since.
79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.